Irisin: 'Fat' or artefact

Clinical Endocrinology

Volumn 82, Issue 4, 2015, Pages 467-474

  Crujeiras, A B ^a,b   Pardo, M ^a,b   Casanueva, Felipe F ^a,b  

^a Instituto de Salud Carlos III   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; IRISIN; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; FNDC5 PROTEIN, RAT; GLUCOSE; LIPID;

ADIPOSE TISSUE; HUMAN; METABOLIC DISORDER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; REVIEW; ANIMAL; BODY WEIGHT; CHEMISTRY; DIABETES MELLITUS; DISEASE MODEL; GENE EXPRESSION REGULATION; HOMEOSTASIS; INSULIN RESISTANCE; METABOLISM; MOUSE; PHYSIOLOGY; RAT; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPOSE TISSUE, WHITE; ANIMALS; BODY WEIGHT; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FIBRONECTINS; GENE EXPRESSION REGULATION; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPIDS; MICE; OBESITY; RATS;

EID: 84924053395     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12627     Document Type: Review

References (56)

1. Bostrom, P., Wu, J., Jedrychowski, M.P., et al,. (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481, 463-468.
2. Wu, J., Bostrom, P., Sparks, L.M., et al,. (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell, 150, 366-376.
3. Hojlund, K., &, Bostrom, P., (2013) Irisin in obesity and type 2 diabetes. Journal of Diabetes and Its Complications, 27, 303-304.
4. Vamvini, M.T., Aronis, K.N., Panagiotou, G., et al,. (2013) Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. European Journal of Endocrinology, 169, 829-834.
5. Zhang, H.J., Zhang, X.F., Ma, Z.M., et al,. (2013) Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. Journal of Hepatology, 59, 557-562.
6. Huh, J.Y., Panagiotou, G., Mougios, V., et al,. (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism: Clinical and Experimental, 61, 1725-1738.
7. Timmons, J.A.B.K., Davidsen, P.K., &, Atherton, P.J., (2012) Is irisin a human exercise gene? Nature, 488, E9-E10.
8. Crujeiras, A.B., Pardo, M., Arturo, R.R., et al,. (2014) Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. American Journal of Human Biology, 26, 198-207.
9. Roca-Rivada, A., Castelao, C., Senin, L.L., et al,. (2013) FNDC5/irisin is not only a myokine but also an adipokine. PLoS One, 8, e60563.
10. Stengel, A., Hofmann, T., Goebel-Stengel, M., et al,. (2012) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides, 39C, 125-130.
11. Pardo, M., Crujeiras, A.B., Amil, M., et al,. (2014) Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. International Journal of Endocrinology, 2014, 857270.
12. Crujeiras, A.B., Zulet, M.A., Lopez-Legarrea, P., et al,. (2014) Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism: Clinical and Experimental, 63, 520-531.
13. de la Iglesia, R., Lopez-Legarrea, P., Crujeiras, A.B., et al,. (2014) Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clinical Endocrinology (Oxford), 81, 306-311.
14. Lopez-Legarrea, P., de la Iglesia, R., Crujeiras, A.B., et al,. (2014) Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects. Nutrition & Diabetes, 4, e110.
15. Brenmoehl, J., Albrecht, E., Komolka, K., et al,. (2014) Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise. International Journal of Biological Sciences, 10, 338-349.
16. Raschke, S., Elsen, M., Gassenhuber, H., et al,. (2013) Evidence against a beneficial effect of irisin in humans. PLoS One, 8, e73680.
17. Schumacher, M.A., Chinnam, N., Ohashi, T., et al,. (2013) Structure of irisin reveals a novel intersubunit beta-sheet fibronectin (FNIII) dimer; implications for receptor activation. Journal of Biological Chemistry, 288, 33738-33744.
18. Norheim, F., Langleite, T.M., Hjorth, M., et al,. (2014) The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans. FEBS Journal, 281, 739-749.
19. Aydin, S., Kuloglu, T., Aydin, S., et al,. (2014) Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides, 52, 68-73.
20. Scharhag-Rosenberger, F., Morsch, A., Wegmann, M., et al,. (2014) Irisin does not mediate resistance training-induced alterations in RMR. Medicine and Science in Sports and Exercise, 46, 1736-1743.
21. Hofmann, T., Elbelt, U., Ahnis, A., et al,. (2014) Irisin levels are not affected by physical activity in patients with anorexia nervosa. Frontiers in Endocrinology, 4, 202.
22. Kurdiova, T., Balaz, M., Vician, M., et al,. (2014) Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. Journal of Physiology, 592, 1091-1107.
23. Hecksteden, A., Wegmann, M., Steffen, A., et al,. (2013) Irisin and exercise training in humans-results from a randomized controlled training trial. BMC Medicine, 11, 235.
24. Kurdiova, T., Balaz, M., Mayer, A., et al,. (2014) Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes. Peptides, 56, 1-7.
25. Fain, J.N., Company, J.M., Booth, F.W., et al,. (2013) Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs. Metabolism: Clinical and Experimental, 62, 1503-1511.
26. Huh, J.Y., Mougios, V., Skraparlis, A., et al,. (2014) Irisin in response to acute and chronic whole-body vibration exercise in humans. Metabolism: Clinical and Experimental, 63, 918-921.
27. Aydin, S., Aydin, S., Kuloglu, T., et al,. (2013) Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running. Peptides, 50, 13-18.
28. Kraemer, R.R., Shockett, P., Webb, N.D., et al,. (2014) A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Hormone and Metabolic Research, 46, 150-154.
29. Moreno-Navarrete, J.M., Ortega, F., Serrano, M., et al,. (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism, 98, E769-E778.
30. Choi, Y.K., Kim, M.K., Bae, K.H., et al,. (2013) Serum irisin levels in new-onset type 2 diabetes. Diabetes Research and Clinical Practice, 100, 96-101.
31. Liu, J.J., Wong, M.D., Toy, W.C., et al,. (2013) Lower circulating irisin is associated with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 27, 365-369.
32. Park, K.H., Zaichenko, L., Brinkoetter, M., et al,. (2013) Circulating irisin in relation to insulin resistance and the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 98, 4899-4907.
33. Staiger, H., Bohm, A., Scheler, M., et al,. (2013) Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin. Determines insulin sensitivity. PLoS One, 8, e61903.
34. Sesti, G., Andreozzi, F., Fiorentino, T.V., et al,. (2014) High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetologica, 51, 705-713.
35. Sanchis-Gomar, F., Alis, R., Pareja-Galeano, H., et al,. (2014) Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine, 46, 674-677.
36. Roberts, M.D., Bayless, D.S., Company, J.M., et al,. (2013) Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism: Clinical and Experimental, 62, 1052-1056.
37. Yan, B., Shi, X., Zhang, H., et al,. (2014) Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS One, 9, e94235.
38. Hofmann, T., Elbelt, U., &, Stengel, A., (2014) Irisin as a muscle-derived hormone stimulating thermogenesis-a critical update. Peptides, 54C, 89-100.
39. Novelle, M.G., Contreras, C., Romero-Pico, A., et al,. (2013) Irisin. Two years later. International Journal of Endocrinology, 2013, 746281.
40. Elsen, M., Raschke, S., &, Eckel, J., (2014) Browning of white fat: does irisin play a role in humans? Journal of Endocrinology, 222, R25-R38.
41. Erickson, H.P., (2013) Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte, 2, 289-293.
42. Sanchis-Gomar, F., Alis, R., Pareja-Galeano, H., et al,. (2014) Inconsistency in circulating irisin levels: what is really happening? Hormone and Metabolic Research, 46, 591-596.
43. Cunha, A., (2012) Basic research: irisin-behind the benefits of exercise. Nature Reviews. Endocrinology, 8, 195.
44. Kelly, D.P., (2012) Medicine. Irisin, light my fire. Science, 336, 42-43.
45. Wen, M.S., Wang, C.Y., Lin, S.L., et al,. (2013) Decrease in irisin in patients with chronic kidney disease. PLoS One, 8, e64025.
46. Emanuele, E., Minoretti, P., Pareja-Galeano, H., et al,. (2014) Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity. American Journal of Medicine, 127, 888-890.
47. Lecker, S.H., Zavin, A., Cao, P., et al,. (2012) Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circulation. Heart failure, 5, 812-818.
48. Rana, K.S., Arif, M., Hill, E.J., et al,. (2014) Plasma irisin levels predict telomere length in healthy adults. Age, 36, 995-1001.
49. Swick, A.G., Orena, S., &, O'Connor, A., (2013) Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism: Clinical and Experimental, 62, 1070-1073.
50. Mohammadzadeh, G., &, Zarghami, N., (2013) Serum leptin level is reduced in non-obese subjects with type 2 diabetes. International Journal of Endocrinology and Metabolism, 11, 3-10.
51. Correia, M.L., &, Rahmouni, K., (2006) Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes, Obesity & Metabolism, 8, 603-610.
52. Gouni-Berthold, I., Berthold, H.K., Huh, J.Y., et al,. (2013) Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo. PLoS One, 8, e72858.
53. Polyzos, S.A., Kountouras, J., Anastasilakis, A.D., et al,. (2013) Irisin in patients with nonalcoholic fatty liver disease. Metabolism: Clinical and Experimental, 62, 1037-1044.
54. Gratas-Delamarche, A., Derbre, F., Vincent, S., et al,. (2013) Physical inactivity, insulin resistance, and the oxidative-inflammatory loop. Free Radical Research, 48, 93-108.
55. Crujeiras, A.B., Diaz-Lagares, A., Carreira, M.C., et al,. (2013) Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radical Research, 47, 243-256.
56. Vincent, H.K., Innes, K.E., &, Vincent, K.R., (2007) Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes, Obesity & Metabolism, 9, 813-839.